CD209e Antibodies

Santa Cruz Biotechnology offers a broad range of CD209e monoclonal antibodies for investigating CD209e protein function. CD209e monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD209e, also known as DC-SIGN, is a C-type lectin receptor that plays a crucial role in the immune response by mediating the recognition of pathogens and facilitating their uptake by dendritic cells. CD209e is essential for the activation of T cells and the modulation of immune responses, making it a significant target for research in immunology and infectious diseases. Understanding CD209e function can provide insights into its potential as a therapeutic target in various diseases. CD209e monoclonal antibodies enable detailed examination of protein expression patterns across different cell types and tissues. Researchers can utilize CD209e monoclonal antibodies to explore cellular localization and protein-protein interactions. CD209e monoclonal antibodies from Santa Cruz Biotechnology support the scientific community in advancing our understanding of immune system regulation and disease mechanisms.